Disease detection, access to care and remote patient monitoring are just a few areas in which AI is expected to aid rheumatology, but there will still be room for the human touch.
The proposed changes aim to address modern breach and cybersecurity risks to electronic protected health information and common deficiencies observed by the HHS in Security Rule compliance investigations.
‘Prior authorizations are the bane of our existence as rheumatologists,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘How bad is it, how can we manage them, and how is the ACR helping? Read on in this month’s Editor’s Pick.’ Healthcare providers consider prior authorization (PA) a significant burden, but to different degrees…
Daniel H. Solomon, MD, MPH, & Andrew Concoff, MD, FACR |
Guest columnists Dr. Daniel Solomon & Dr. Andrew Concoff discuss the potential of technology, such as mobile health apps, to enhance remote care & improve access for underserved patients.
Daniel H. Solomon, MD, MPH, & Andrew Concoff, MD, FACR |
Over our 25 years as rheumatologists, care has advanced greatly. We each completed our rheumatology training in the late 1990s when both infliximab and etanercept first arrived on the U.S. market, ushering in the era of biologics in rheumatology. Since this time, our greater understanding of the immunologic basis of many rheumatic diseases has translated…
Long wait times for appointments, the rheumatologist shortage in rural areas—does telehealth solve some aspects of access to care for rheumatology patients? Three experts highlighted the data on remote care, unveiling surprising truths and misconceptions.
Hosted by Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, physician editor, The Rheumatologist Amidst mounting excitement over emerging artificial intelligence tools, Dr. Kumar cautions against the expectation that technology will offer a quick fix to complex, systemic healthcare problems. Go to current issue.
Chatbots are not a new concept, but have recently gained popularity and traction. Launched in late 2022, ChatGPT (Chat Generative Pre-Trained Transformer) is a web-based platform designed to simulate interactive conversations and deliver real-time data. It has quickly become a tool that provides instantaneous information that can be more focused than a Google search.1 We,…
A handful of articles on artificial intelligence (AI) have graced the pages of this publication in the past six years, including one by Bharat Kumar, MD, in November 2022. Dr. Kumar highlighted the exciting potential of AI in rheumatology, including machine learning (ML) algorithms for the prediction of response to methotrexate and a predictive model…